Drug Topics March 24, 2024
In a conversation at this year’s American Pharmacists Association Annual Meeting & Exposition, Sa’ed Al-Olimat outlined the potential of psychedelic therapeutics in treating mental health disorders.
According to Sa’ed Al-Olimat, PharmD, co-founder of the Psychedelic Pharmacists Association, the current psychedelic landscape is rapidly evolving. Even though psychedelics are still classified as illegal substances in most jurisdictions, the range of potential indications for drugs like ketamine—described by Al-Olimat as the “wild west”—MDMA, and psilocybin are being explored for a variety of promising medical uses.
“What’s interesting is that we see all of these potential indications used for these psychedelics, and that’s why they’re labeled as transdiagnostic agents,” said Al-Olimat in a conversation with Drug Topics at this year’s American Pharmacists Association...
Today's Sponsors
Today's Sponsor